Algert Global’s Mustang Bio MBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-87
Closed -$216K 1053
2021
Q2
$216K Buy
87
+5
+6% +$12.3K 0.07% 339
2021
Q1
$204K Hold
82
0.07% 375
2020
Q4
$233K Hold
82
0.07% 332
2020
Q3
$194K Buy
82
+60
+273% +$148K 0.06% 318
2020
Q2
$53K Sell
22
-10
-31% -$23.4K 0.02% 394
2020
Q1
$65K Buy
+32
New +$82K 0.03% 377

Other funds holding MBIO

Algert Global's MBIO Position: Q3 2021 in Review

Algert Global sold out of Mustang Bio (MBIO) in Q3 2021, closing a stake of 87 shares — an estimated $216K sold.

Algert Global first reported a position in MBIO in Q1 2020 and held it in 6 quarters. The position peaked at $233K in Q4 2020. 79 funds tracked by Wall St. Rank hold MBIO as of Q3 2021.

  • Algert Global reported no remaining Mustang Bio position as of Q3 2021 after selling out during the quarter.
  • Algert Global sold 87 Mustang Bio shares in Q3 2021, an estimated $216K.
  • Algert Global first reported a position in Mustang Bio in Q1 2020 and held it in 6 quarters.
  • Algert Global's Mustang Bio position peaked at $233K in Q4 2020.
  • 79 funds tracked by Wall St. Rank held Mustang Bio as of Q3 2021.

Based on Algert Global's 13F filing for Q3 2021, filed 15 Nov 2021.